Molecular pathology and pathogenesis of inclusion-body myositis

Microsc Res Tech. 2005 Jul;67(3-4):114-20. doi: 10.1002/jemt.20186.

Abstract

We summarize the molecular phenotype, diagnostic criteria, and the newest advances related to seeking the pathogenic mechanism(s) of sporadic inclusion-body myositis (s-IBM), a muscle disease usually of persons over age 50. On the basis of our research, several processes seem to be important in relation to the still-speculative pathogenesis: 1) increased transcription and accumulation of amyloid-beta precursor protein (AbetaPP), and accumulation of its proteolytic fragment Abeta; 2) abnormal accumulation of cholesterol, caveolin-1, and apolipoprotein E; 3) oxidative stress; 4) accumulations of intramuscle fiber multiprotein aggregates; and 5) evidence that unfolded/misfolded proteins participate in s-IBM pathogenesis. Our basic hypothesis is that overexpression of AbetaPP within the aging muscle fibers is an early upstream event causing a subsequent pathogenic cascade.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Aging / metabolism
  • Aging / pathology
  • Amyloid beta-Protein Precursor / genetics
  • Amyloid beta-Protein Precursor / metabolism
  • Apolipoproteins E / metabolism
  • Caveolin 1 / metabolism
  • Cholesterol / metabolism
  • Humans
  • Muscle Fibers, Skeletal / metabolism
  • Muscle Fibers, Skeletal / ultrastructure
  • Mutation
  • Myositis, Inclusion Body / etiology*
  • Myositis, Inclusion Body / metabolism
  • Myositis, Inclusion Body / pathology
  • Oxidative Stress
  • Protein Folding

Substances

  • Amyloid beta-Protein Precursor
  • Apolipoproteins E
  • Caveolin 1
  • Cholesterol